Michael Kauffman, MD and CEO from Karyopharm Therapeutics Inc discusses a new oral compound, Selinexor and how it can be safely combined with different drugs for efficacy at the 2017 American Society of Hematology.
Advertisement
New Oral Compound, Selinexor – Selinexor can be safely combined with different drugs for efficacy
